P

Inventor

KING DAVID J

US39 patents
⚠️ This page may combine multiple inventors who share the name “KING DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ANAPTYSBIO INC

16 patents
US9815897B2Nov 14, 2017

Antibodies directed against programmed death-1 (PD-1)

ANAPTYSBIO INC24 citations93
US9133269B2Sep 15, 2015

Humanized antibodies directed against complement protein C5

ANAPTYSBIO INC20 citations87
US10738117B2Aug 11, 2020

Antibodies directed against programmed death-1 (PD-1)

ANAPTYSBIO INC10 citations83
US10059764B2Aug 28, 2018

Antibodies directed against interleukin-33 (IL-33) and methods of making and using

ANAPTYSBIO INC6 citations82
US10526410B2Jan 7, 2020

Antibodies directed against interleukin 36 receptor (IL-36R)

ANAPTYSBIO INC7 citations81
US10508149B2Dec 17, 2019

Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

ANAPTYSBIO INC7 citations80
US10836820B2Nov 17, 2020

Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)

ANAPTYSBIO INC1 citations71
US11130814B2Sep 28, 2021

Method of treating pustular psoriasis with antibodies directed against interleukin 36 receptor (IL-36R)

ANAPTYSBIO INC2 citations70
US11352427B2Jun 7, 2022

Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3)

ANAPTYSBIO INC2 citations69
US11155624B2Oct 26, 2021

Antibodies directed against programmed death-1 (PD-1)

ANAPTYSBIO INC4 citations69
US11753472B2Sep 12, 2023

Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

ANAPTYSBIO INC2 citations65
US11999783B2Jun 4, 2024

Method of treating autoimmune disease with antibodies against IL-33

ANAPTYSBIO INC0 citations61
US12391761B2Aug 19, 2025

Antibodies directed against interleukin 36 receptor (IL-36R)

ANAPTYSBIO INC0 citations59
US10836824B2Nov 17, 2020

Antibodies directed against lymphocyte activation gene 3 (LAG-3)

ANAPTYSBIO INC1 citations59
US9951126B2Apr 24, 2018

Antibodies directed against nerve growth factor (NGF)

ANAPTYSBIO INC0 citations47
US8926978B2Jan 6, 2015

Antibodies directed against nerve growth factor (NGF)

ANAPTYSBIO INC0 citations47

MASTERCARD INTERNATIONAL INC

6 patents

MEDAREX INC

4 patents

MOMENTA PHARMACEUTICALS INC

3 patents

UNIV TEXAS

2 patents

LASSEN THERAPEUTICS INC

2 patents

LIGHTWAVE PHOTONICS INC

1 patent

TRI LYNX CORP

1 patent

TRI LYNX CORP LTD

1 patent

LIFE TECHNOLOGIES CORP

1 patent

LASSEN THERAPEUTICS 1 INC

1 patent

JORGENSON ROBBIE J

1 patent